Not the same as it used to be - Research Chemist bei Merck: Mitarbeiterbewertung

3.0
19. Nov. 2008
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Flextime. Pretty good benefits and up until recently, after restructuring, there was good career development opportunities

Kontras

Bad press coverage over several product (fair and unfair) have brought the company to its knees, in my opinion. financially, it is still sound but the entire culture has changed as a result. It was rough going under the economic climate already but the fallout from Vioxx and other product-related problems have really hurt the brand which has just made things worse.

Mehr Bewertungen zu Merck entdecken

5.0
3. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

End of the year shutdown which includes paid time off

Kontras

The con for me at the time was that I had to relocate which wasn’t possible

4.0
2. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Kontras

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle